Perioperative Cardiac Arrest and Outcome (POCA)

October 26, 2023 updated by: Insel Gruppe AG, University Hospital Bern

Perioperative Cardiac Arrest: an Observational Mono-centre 8-year Assessment of Outcome

With ethical approvement, the investigators want to assess the incidence, circumstances and outcomes of patients with perioperative cardiac arrests over a period of 8 years.

Currently, there is little data and information about a cardiovascular arrests during anesthesia. Little is also known about the health-related quality of life afterwards. In the investigators research project, the investigators want to find out if there are, for example, specific factors that cause cardiovascular arrests and factors that can improve the chances of survival after a cardiovascular arrest. The investigators are also looking for possible factors and measurements that can minimize or even prevent future events during anesthesia.

Study Overview

Status

Completed

Detailed Description

A perioperative cardiac arrest is a special form of in-hospital cardiac arrest. It was claimed that perioperative cardiac arrests are under-investigated. The spare existing data suggest incidences of perioperative cardiac arrest to be between 0.5 - 3 per 10.000 for adult patients and 2 - 10 per 10.000 for paediatric patients. Data on circumstances, predictors and outcomes of perioperative cardiac arrest are rare, especially for paediatric patients. Some reports suggest that incidence is negatively associated with a country's higher development. As no Swiss data is available on this topic, this retrospective audit aims to bridge the knowledge gap and finally intends to make clinicians aware of potential risks or contributing factors of survival, which might raise safety for all patients undergoing procedures under anaesthesia.

The investigators will include all patients of all ages with a perioperative cardiac arrest at Bern University Hospital from 1st January 2015 until 31st December 2021 (7 year observational period).

Study Type

Observational

Enrollment (Actual)

240

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Bern, Switzerland, 3010
        • University Hospital Bern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The investigators will include all patients of all ages with a perioperative cardiac arrest at Bern University Hospital from 1st January 2015 until 31st December 2021.

Description

Inclusion Criteria is a perioperative cardiac arrest between 1st January 2015 and 31st December 2021 at Bern University Hospital.

A perioperative cardiac arrest is defined as:

  • ≥5 chest compressions (direct, mechanical or extracorporeal Cardiopulmonary Resuscitation (CPR))
  • and/or defibrillation (unsynchronised direct current (DC) shock for ventricular fibrillation (VF) or pulseless ventricular tachycardia (pVT) either - external or internal defibrillation with manual or Automated External Defibrillation (AED), shocks by implanted cardioverter defibrillators (ICDs) for VF/pVT, precordial thump)
  • In a patient having a procedure under the care of an anaesthesia team (nurse or anaesthesiologist) at the Bern University Hospital: General anaesthesia, regional anaesthesia/ analgesia, sedation, local anaesthesia or monitored anaesthesia care
  • Regional block performed by anaesthesiologist outside of operating room
  • Obstetric analgesia including remifentanil patient-controlled analgesia (PCA).

Exclusion Criteria:

  • A perioperative cardiac arrest before 1st January 2015 or after 31st December 2021
  • <5 chest compressions (direct, mechanical or extracorporeal Cardiopulmonary Resuscitation (CPR))
  • All in-hospital cardiac arrests, that occur without being under anaesthesia care
  • Patients already admitted to a hospital with a cardiac arrest (out-of hospital cardiac arrests)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Return of spontaneous circulation (ROSC)
Time Frame: 60 minutes
Number of patients with a Return of spontaneous circulation (ROSC) during resuscitation
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sustained ROSC
Time Frame: 60 minutes
Number of patients with a Return of spontaneous circulation during resuscitation over 20 minutes
60 minutes
Survival post-anaesthesia care unit or intensive care unit
Time Frame: 24 hours
Number of patients with a Survival to post-anaesthesia care unit (PACU) or intensive care unit (ICU)
24 hours
Survival to hospital discharge
Time Frame: 4 weeks
Number of patients with a Survival to hospital discharge
4 weeks
SF-12 after hospital discharge
Time Frame: 1 month
Health-related quality of life according (HRQOL) the Short Form Survey (SF-12) after hospital discharge
1 month
CPC after hospital discharge
Time Frame: 1 month
Neurological status according Clinical Performance Category (CPC) after hospital discharge
1 month
SF-12 3 month after cardiac arrest
Time Frame: 3 months
Health-related quality of life (HRQOL) according the Short Form Survey (SF-12) at 3 months after the peri-operative cardiac arrest
3 months
CPC 3 month after cardiac arrest
Time Frame: 3 months
Neurological status according Clinical Performance Category (CPC) at 3 months after the peri-operative cardiac arrest
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Robert Greif, MD, Prof, University of Bern

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 14, 2022

Primary Completion (Actual)

September 26, 2023

Study Completion (Actual)

October 25, 2023

Study Registration Dates

First Submitted

March 21, 2022

First Submitted That Met QC Criteria

March 30, 2022

First Posted (Actual)

April 7, 2022

Study Record Updates

Last Update Posted (Actual)

October 27, 2023

Last Update Submitted That Met QC Criteria

October 26, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Arrest

3
Subscribe